Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
Authors:
Open Access
- 10 October 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1264205
Abstract
Sarcopenia is characterized by the loss of muscle mass and function. It is well known that sarcopenia is often associated with aging, while in recent years, sarcopenia comorbid with chronic diseases such as cirrhosis has attracted widespread attention, whose underlying molecular mechanisms remain unclear. Since cirrhosis and sarcopenia are assumed to be closely interrelated in terms of pathogenesis, this review innovatively discussed the role of epigenetic modifications and microecological dysregulation in sarcopenia in the context of liver cirrhosis. Here we illustrated the relationship between sarcopenia and cirrhosis in the aspect of epigenetics, dysbiosis, and the crosstalk between gene modifications and intestinal microecology. Furthermore, the alterations in cirrhosis patients with sarcopenia, such as inflammatory response and oxidative stress, are found to present synergistic effects in the pathways of epigenetics and dysbiosis leading to sarcopenia. This review proposes that microbiome-based therapies are promising to break the vicious cycle between epigenetic modification and dysbiosis, providing strong support for the use of intestinal microecological interventions to prevent sarcopenia in cirrhotic patients.Keywords
Funding Information
- Guangzhou Science, Technology and Innovation Commission (202002030101)
- National Natural Science Foundation of China (81300370)
- Natural Science Foundation of Guangdong (2018A030313161)
This publication has 79 references indexed in Scilit:
- The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during agingAging Cell, 2015
- Alterations of the human gut microbiome in liver cirrhosisNature, 2014
- Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasisNature, 2013
- Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB–mediated mechanismProceedings of the National Academy of Sciences of the United States of America, 2013
- Muscle wasting: The gut microbiota as a new therapeutic target?The International Journal of Biochemistry & Cell Biology, 2013
- Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box ProteinsCell, 2013
- Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubesLife Sciences, 2009
- Diversity of the Human Intestinal Microbial FloraScience, 2005
- Oxidative Stress in the Liver and Biliary Tract DiseasesScandinavian Journal of Gastroenterology, 1998
- Oxidative damage and fibrogenesisFree Radical Biology and Medicine, 1997